What hormones should be checked in a case of empty sella syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hormonal Evaluation in Empty Sella Syndrome

Direct Answer

All patients with empty sella should undergo comprehensive hormonal screening including thyroid function tests (TSH, free T4), morning cortisol and ACTH, sex hormones (testosterone in males, estradiol in females, FSH, LH), prolactin, and IGF-1 to assess the growth hormone axis, regardless of whether they have symptoms. 1, 2, 3

Rationale for Comprehensive Screening

The evidence strongly supports universal hormonal testing in empty sella cases:

  • Approximately 30% of patients with empty sella demonstrate some degree of hypopituitarism upon testing, though most remain asymptomatic 4, 1, 3
  • Hormonal abnormalities occur in 37.5-52% of patients with empty sella, with affected-axis rates often exceeding 10% and potentially reaching 50% 3, 5, 6
  • The most commonly affected hormones are cortisol (20-62.5% of cases), thyroid function (up to 48-50%), prolactin (elevated in 13.8-28%), and sex hormones 1, 7, 5

Specific Hormonal Panel to Order

Essential Baseline Tests

Morning (8 AM) measurements are critical for accurate assessment: 2

  • Thyroid axis: TSH and free T4 to detect central hypothyroidism (low/normal TSH with low free T4) 1, 2
  • Adrenal axis: Morning cortisol and ACTH to assess for secondary adrenal insufficiency 1, 2
  • Gonadal axis: Testosterone (males), estradiol (females), FSH, and LH to detect hypogonadotropic hypogonadism 1, 2
  • Prolactin: To identify hyperprolactinemia, which occurs in approximately 13.8-28% of cases 1, 7
  • Growth hormone axis: IGF-1 to screen for GH deficiency 2, 6

Additional Considerations

  • If baseline morning cortisol is equivocal (typically 3-15 mcg/dL), perform a 1 mcg cosyntropin stimulation test to definitively assess adrenal function 2
  • These tests must be performed prior to initiating steroid therapy to avoid interference with results 2

Clinical Context Matters

Complete vs. Partial Empty Sella

Patients with complete empty sella (≥50% CSF filling, pituitary <2 mm) have significantly higher rates of hormonal dysfunction compared to partial empty sella: 5

  • Secondary adrenal insufficiency and hypogonadism are significantly more common in complete empty sella (p = 0.021 and p = 0.041, respectively) 5
  • Two or more affected axes occur more frequently in complete empty sella (p = 0.010) 5
  • However, hormonal testing is advisable for all PES patients regardless of type, as affected-axis rates often exceed 10% even in partial cases 5

Interpretation Patterns

Central hormone deficiencies present differently than primary endocrine disorders: 2

  • Central hypothyroidism: Low free T4 with low or inappropriately normal TSH (not elevated as in primary hypothyroidism) 2
  • Central adrenal insufficiency: Low cortisol with low or inappropriately normal ACTH 2
  • Hypogonadotropic hypogonadism: Low testosterone/estradiol with low or inappropriately normal FSH and LH 2

Critical Management Pitfall

If both adrenal insufficiency and hypothyroidism are detected, always initiate steroid replacement before thyroid hormone replacement to avoid precipitating an adrenal crisis 2

When to Refer to Endocrinology

Endocrinology referral is indicated if: 1, 3

  • Any hormonal abnormalities are detected on screening 1, 3
  • Patient has symptoms suggestive of pituitary dysfunction (fatigue, cold intolerance, sexual dysfunction, visual changes) 1
  • Multiple hormone axes are affected 2

Imaging Confirmation

MRI using high-resolution pituitary protocols is the gold standard for confirming empty sella, and can be performed even without IV contrast 1, 2, 8

References

Guideline

Management of Incidental Partially Empty Sella in a Patient with Headache

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Pituitary Function Tests: Recommendations and Indications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Partially Empty Sella

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Study of prevalence of endocrine abnormalities in primary empty sella.

Indian journal of endocrinology and metabolism, 2013

Research

Empty sella syndrome: an update.

Pituitary, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.